Centruroides immune Fab (equine)

Drug Profile

Centruroides immune Fab (equine)

Alternative Names: Anascorp; Scorpion immune Fab (equine)

Latest Information Update: 18 Mar 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Rare Disease Therapeutics
  • Class Antibodies; Antivenins; Fab fragments
  • Mechanism of Action Scorpion venom inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Scorpion venom poisoning
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Scorpion venom poisoning

Most Recent Events

  • 03 Aug 2011 Registered for Scorpion venom poisoning in USA (IV)
  • 03 Aug 2011 Efficacy and adverse events data from a clinical trial in Scorpion venom poisoning released by the US FDA
  • 24 Aug 2005 Phase-II clinical trials in Scorpion venom poisoning in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top